SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-19-217043
Filing Date
2019-08-08
Accepted
2019-08-08 17:30:02
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d786429d8ka.htm 8-K/A 20354
2 EX-99.1 d786429dex991.htm EX-99.1 60210
3 GRAPHIC g786429g0808094255625.jpg GRAPHIC 4527
  Complete submission text file 0001193125-19-217043.txt   88141
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36183 | Film No.: 191010735
SIC: 2836 Biological Products, (No Diagnostic Substances)